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Understanding prebiotic nucleotide synthesis is a long standing challenge thought to be
essential to elucidating the origins of life on Earth. Recently, remarkable progress has been
made, but to date all proposed syntheses account separately for the pyrimidine and purine
ribonucleotides; no divergent synthesis from common precursors has been proposed.
Moreover, the prebiotic syntheses of pyrimidine and purine nucleotides that have been
demonstrated operate under mutually incompatible conditions. Here, we tackle this mutual
incompatibility by recognizing that the 8-oxo-purines share an underlying generational parity
with the pyrimidine nucleotides. We present a divergent synthesis of pyrimidine and
8-oxo-purine nucleotides starting from a common prebiotic precursor that yields the
b-ribo-stereochemistry found in the sugar phosphate backbone of biological nucleic acids.
The generational relationship between pyrimidine and 8-oxo-purine nucleotides suggests that
8-oxo-purine ribonucleotides may have played a key role in primordial nucleic acids prior to
the emergence of the canonical nucleotides of biology.
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R
ibonucleotide synthesis is a key unmet requirement upon
which the origin of life on Earth is contingent1–3. Recent
progress towards prebiotic ribonucleotide synthesis
uniformly fails to account for simultaneous access to both
pyrimidine4–6 and purine7–11 nucleotides, both of which are
required to generate RNA. Despite purine nucleobase synthesis by
hydrogen cyanide oligomerization being ﬁrst reported more than
60 years ago3,9–11, purine nucleobases and adenosine nucleotides
are only accessible in low yields and with poor regio- and
stereoselectivity7,11. While, a prebiotically plausible synthesis of
both pyrimidine ribonucleotides has been established4–6, the
glycosidations of adenine and hypoxanthine generate a complex
mixture of nucleoside-like products, and there is no literature
precedent for the direct glycosidation of guanine to furnish
guanosine (G)3,11. A notable proposed pathway to the purine
nucleotides, that achieves excellent N9-selectivity during
ribosylation7, remains problematic because of an unselective
ribosylation (that furnished a mixture of natural furanosyl and
non-natural pyranosyl isomers, and a mixture of natural
b-anomers and non-natural a-anomers). Furthermore, this
strategy, a variant of the classic Traube purine synthesis8,
generates a wide spectrum of glycone isomers, homologues and
anomers alongside a low yield of natural nucleosides from
prebiotically plausible sugar mixtures7. Therefore, in an inversion
to the status quo of more than 50 years, a selective prebiotically
plausible purine synthesis is now the most signiﬁcant problem
associated with prebiotic assembly of the RNA monomers.
Remarkably, all proposed prebiotic syntheses of pyrimidine
and purine nucleotides have yielded either pyrimidines or purines
separately, but never (yet) both by the same strategy4–7,9–12; while
purine nucleotides can be synthesized by direct ribosylation,
pyrimidine nucleotides cannot and though a complete stepwise
pyrimidine nucleotide synthesis has been demonstrated
(even from complex sugar mixtures5) a comparable strategy for
purine synthesis remains elusive4–6. Constitutional analysis of
purine and pyrimidine ribonucleotides suggests that nucleobase
construction on a preformed sugar moiety would provide the
simplest strategy for divergent monomer synthesis (Fig. 1). Given
the lack of speciﬁcity observed during direct glycosidation of
purine nucleobases, we have previously suggested that a tethered
purine synthesis would overcome the limitation of intramolecular
glycosidation13,14. Although the optimal tethering-site to direct
stereo- and regiospeciﬁc purination is not clear; it is of particular
note that the canonical purine nucleotides, unlike the pyrimidine
nucleotides, display signiﬁcant variation in their oxidation level.
Nucleosides A and G are both universal and essential to biology,
but interestingly they have different oxidation levels. We there-
fore hypothesized that the inherent ﬂexibility in purine oxidation
level may shed light upon the ideal prebiotic tether to allow
divergent purine and pyrimidine synthesis. Purines particularly
have a high propensity for C8-oxidation and 8-oxo-guanine
(OG), for example, which though commonly mutagenic because
it may give rise to G:C to T:A transversions via DNA Hoogsteen
OG:A base pairs, is remarkably well tolerated during information
transfer in Watson–Crick OG:C base pairs15–21. Moreover,
E. coli DNA polymerase I and Taq DNA polymerase have both
been observed to exclusively insert a correct thymine (T)
nucleotide when reading through 8-oxo-adenine (OA)
incorporated into gene fragments22. Importantly, with respect
to analysis of selective purine nucleotide assembly, C8-oxidation
appears to provide an ideally positioned tether for prebiotic
purine nucleobase assembly by an approach that is uniﬁed with
prebiotic pyrimidine synthesis. Here, we demonstrate a divergent,
prebiotically plausible reaction strategy for the synthesis of
both pyrimidine and purine ribonucleotides (3) on a single
oxazoline scaffold.
Results
Overview. We envisaged that a purine-8,20-anhydronucleoside
linkage could be exploited to deliver regio- and stereospeciﬁc
glycosidation, with direct generational parity to prebiotic
pyrimidine synthesis via a pyrimidine-2,20-anhydronucleoside
intermediate (Fig. 2)4. We hypothesized that positioning sulfur at
the C2-carbon atom of an oxazolidinone thione (1), followed by
chemoselective sulﬁde-activation and amine displacement,
would provide the chemical differentiation required for
divergent pyrimidine (amine¼ ammonia, 2a) and 8-oxo-purine
(amine¼HCN-trimer, 2b–c) nucleotide synthesis from one
common precursor. A common thione precursor would
bypass the unstable free sugars and problematic direct purine
nucleobase glycosidation, and move us a step closer to
understanding the uniﬁed origins of purine and pyrimidine
nucleotides in biology.
Furanosyl-selective sugar synthesis. Oxazole 4a is a key
ribonucleotide precursor which derives from glycolaldehyde (5)
and cyanamide (6) (Fig. 2)4. The C2-carbon atom of 4a is
regiospeciﬁcally positioned as the C2-pyrimidine carbon atom in
abiotic pyrimidine synthesis upon reaction with glyceraldehyde
(7) and cyanoacetylene (8). To introduce a sulfur atom at the
C2-carbon atom of oxazole 4b, and consequently acquire the
plasticity needed to diverge towards both purine and pyrimidine
nucleotides, we reasoned that synthesis should commence with
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Figure 1 | Proposed prebiotic ribonucleotide synthesis by divergent
nucleobase assembly on a universal furanosyl-oxazoline scaffold.
(a) Unitary phase: the reaction of prebiotically available feedstock
molecules to assemble a universal sugar scaffold. (b) Divergent phase:
single sugar scaffold diverges through congruent reactions to yield both
pyrimidine and purine precursors with controlled furanosyl sugar structure,
pentose selectivity and stereocontrol. R0 ¼CN or CONH2. (c) Convergent
phase: concomitantly synthesized purine and pyrimidine nucleotides are
collectively assembled to yield polymeric RNAs.
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prebiotically plausible thiocyanic acid (9)23–25, which can be
generated quantitatively from hydrogen cyanide and sulfur26.
Treatment of glycolaldehyde (5; 0.1M) with aqueous
thiocyanic acid (9; 0.5M), yields 2-thiooxazole (4b) in 85%
yield (Fig. 2 and Supplementary Fig. 1), and it is also of note that
4b can puriﬁed by crystallization directly from water and can be
transported by sublimation, providing simple prebiotically
plausible mechanisms for puriﬁcation, accumulation and
transport of 2-thiooxazole (4b)27,28. Pleasingly, we found that
at near neutral pH (pH 4–9; Supplementary Table 1) the reaction
of 2-thiooxazole (4b; 0.25M) with glyceraldehyde (7; 0.5–1M) in
water at 60 C yielded a mixture of the pentose oxazolidinone
thiones (1a). The reaction is sluggish below pH 6, but more
rapid above pH 7 yielding up to 74% thione 1a in 24 h. The
reaction proceeds with high ribo-/arabino-diastereoselectivity
(70%, ribo/arabino 1:1; 30% lyxo/xylo), which is of note
because both ribo- and arabino-thiones 1 are only one
stereochemical inversion from the b-ribo-stereochemistry of
RNA. Furthermore, furanosyl selectivity is equally important en
route to RNA, and crystallization of all the diastereomeric
products of the reaction of 2-thiooxazole (4b) and glyceraldehyde
(7) demonstrates that only the minor lyxose component was
furnished as a mixture of furanosyl- and pyranosyl-isomers
(p-lyxo-1a/f-lyxo-1a; 2:1; Supplementary Fig. 4). The ribo-,
arabino- and xylo-isomers are generated with complete
furanosyl selectivity. Synthesis of 1a achieves, in two
prebiotically plausible steps, our ﬁrst goal: to selectively position
sulfur at the C2-position of the pentose oxazolidinones.
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Figure 2 | Divergent ribonucleotide synthesis. Prebiotic assembly of cytidine-20 ,30-cyclic phosphate 3C, uridine-20 ,30-cyclic phosphate 3U, 8-oxo-
adenosine-20,30-cyclic phosphate 3OA and 8-oxo-inosine-20,30-cyclic phosphate 3OI. Glycolaldehyde (5) reacts with cyanamide (6) and thiocyanic acid (9)
to furnish 2-aminooxazole 4a and 2-thiooxazole 4b, respectively. 2-Aminooxazole 4a is a known prebiotic precursor of pyrimidine nucleotides (3C and 3U)
and 2-thiooxazole 4b is demonstrated to be a precursor of both pyrimidine nucleotides (3C and 3U) and 8-oxo-purine nucleotides (3OA and 3OI). Oxazole
4b undergoes reaction with glyceraldehyde (7) to yield thione 1a. Chemical activation of thione 1a provides a second point of divergence (thione 1b),
which yields pyrimidine precursor 10a upon reaction with ammonia (2a) or purine precursors 16b or 16c upon reaction with hydrogen cyanide oligomers
(2b or 2c, respectively). Cyanovinylation and formylation of 10a and 16b/c and subsequent urea-mediated phosphorylation leads to the congruent
synthesis of pyrimidine nucleotides (3C and 3U) and 8-oxo-purine nucleotides (3OA and 3OI). The two points of chemical divergence, Divergence A and
divergence B, are marked with green boxes and the chemical convergence, Convergence, on nucleotide monomers is marked with an orange box.
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Site-speciﬁc thione activation. Next, we investigated the selective
activation of thione 1a. En route to the pyrimidine nucleotides,
cyanovinylation of pentose aminooxazoline 10a occurs with
nearly complete selectivity at the endocyclic N1-nitrogen atom,
followed by rapid annulation to yield anhydronucleoside 11
(Fig. 2). However, it was necessary to introduce stoichiometric
phosphate to maintain pH o7 and prevent hydrolysis of the
2,20-anhydronucleoside linkage that was required for
C20-stereochemical inversion to prebiotically access b-ribonu-
cleotides4. Here, we envisaged cyanoacetylene (8) as ideally suited
to activate thione 1a in aqueous solution due the slow reaction of
cyanoacetylene (8) with water and the excellent electron-
withdrawing properties of the cyanovinyl moiety, that would
activate the C2-carbon atom of 1 to nucleophilic addition29,30.
Pleasingly, we observed quantitative cyanovinylation of thione 1a
(0.25–1M), upon incubation with aqueous cyanoacetylene
(8; 1.1–2 equiv.) with click-like efﬁciency, and complete regio-
and stereocontrol to furnish S-cyanovinyl thione 1b in water at
room temperature in one hour (Supplementary Fig. 5). Due to the
higher pKa of anhydronucleoside 11 than S-cyanovinyl thione
1b31, and sulfur-prohibited annulation, no increase in pH was
observed during cyanovinylation of thione 1a. Increasing pH is a
hallmark of the addition of cyanoacetylene (8) to aminooxazoline
(10a) in water, rendering pH-buffered cyanovinylation essential
to pyrimidine synthesis4, however no buffer was required to
control the reaction of 1a with cyanoacetylene (8). Thus,
cyanoacetylene (8) provides a superbly controlled and
quantitative activation of 1a in water.
Aminooxazoline synthesis. It has been previously noted that
S-alkyl thione 1c is ‘singularly unreactive towards nucleophiles’32,
and to our knowledge, thiolate displacement from 1c (R¼Me) by
ammonia (2a) to yield 10a has only been observed upon
‘treatment with formamide at 90 C for 3 h’ (which was likely
contaminated with ammonium formate and can slowly release
ammonia (2a) and formic acid)33. However, the S-benzyl thione
1d (R¼CH2Ph) has been substituted during quinazolinedione 12
synthesis (Fig. 3)34,35, but reports are limited to anthranilic acid
derivatives in ethanol or t-butanol. We hypothesized that thione
protonation and weak amine solvation were both essential to
these limited examples in formamide or absolute alcohol solvents.
In agreement with literature reports, we do not observe reaction
between S-alkylated thione (1c, R¼Me; pKaH¼ 2.4; see
Supplementary Fig. 11) and ammonia (2a; pKaH¼ 9.2) in
aqueous solution. However, we considered that S-cyanovinyl
thione 1b, due to the greatly increased electron-withdrawing
effect of the cyanovinyl moiety with respect to both methyl and
benzyl moieties, might take part in sulﬁde displacement reactions
even at higher pH where substantial thione protonation would
not occur. Moreover, we also predicted that judiciously chosen
amines would be able to displace even alkyl thiolates at pHs
where the thione is (partially) protonated and the amine is
present as the free-base.
As a preliminary test of our hypotheses and to explore the
prebiotic synthesis of 1c, we investigated thiol exchange. We were
pleased to observe that sequential addition of cyanoacetylene (8)
and methanethiol to thione 1a furnished 1c in up to 50% yield at
pH 6 (Supplementary Fig. 13), demonstrating prebiotically
plausible access to 1c. S-alkyl thione 1c is more stable than
S-cyanovinyl thione 1b, but we predicted that the reactivity of 1c
could be controlled (switched on/off) through protonation. To
test this hypothesized pH-switch, we investigated the synthesis of
quinazolinedione 12 in water (Fig. 3) across a broad pH range.
Interestingly, we observed near-quantitative conversion of 1c to
ribo-12a and arabino-12a in water between pH 2 and 6,
supporting our hypothesis that thione protonation was essential
for the activation of S-alkyl thiones. Moreover the reaction was
severely retarded under alkaline conditions (pH 46, Suppleme-
ntary Fig. 17), demonstrating that the reactivity of 1c is readily
modulated through pH-control. Pleasingly, aqueous cyanovinyla-
tion followed by in situ reaction with anthranilic acid (14)
generated quinazolinedione 12a in water at all pH’s investigated
(pH 3–10). It is of note that the maximal efﬁciency of
displacement occurred at pH 6, where near-quantitative conver-
sion of 0.25M 1b to quinazolinedione 12a was observed within
6 h at room temperature.
We next investigated thione displacement with ammonia
(2a; pKaH¼ 9.2)25, to establish a novel route for the prebiotic
assembly of pyrimidine nucleotides from the precursor 10a. Unlike
the case for simple S-alkyl thiones such as 1c, aqueous ammonia
(2a) efﬁciently displaces thiolate 13 from cyanovinyl thione 1b and
incubation of arabino-1b or ribo-1b (0.25M) with ammonium
chloride (1M, pH 8.5–10.5) returns arabino- and ribo-
aminooxazoline 10a (15–23%), from their respective thiones 1b.
Interestingly, the major by-products are the precursor thione 1a
(37–42%) and a white crystalline precipitate of dicyanovinyl sulﬁde
15 (Fig. 4)36; these by-products suggested regeneration of thione 1a
results from rapid nucleophilic addition of thiolate 13 to the
cyanovinyl moiety of 1b. However, the greatly increased efﬁcacy of
cyanovinylation of 1a suggested that 1b could be regenerated in situ
by reactivation of 1a (in the presence of 10a). Indeed, we observed
that addition of cyanoacetylene (8; 0.25M) to an aqueous solution
of thione 1a (0.24M) and 10a (0.24M) between pH 7 and 10.5, led
to chemospeciﬁc cyanovinylation of 1a, which then reacted with
ammonia to yield aminooxazoline 10a (60%). Furthermore, we
observed that repeated cyanovinylation and incubation of thione 1a
in ammonia solution yielded up to 45% arabino-aminooxazoline
arabino-10a and 33% ribo-aminooxazoline ribo-10a (over two
cycles of cyanovinylation at pH 10.5, without need for any
intermediate steps of puriﬁcation) leading to a remarkably pure
solution of aminooxazoline 10a (Supplementary Figs 18 and 19).
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Figure 3 | Model quinazolinedione synthesis. One-pot cyanovinylation of
arabinofuranosyl-oxazolidinone thione (1a) and quinazolinedione 12a
synthesis in water was tested as a model nucleobase synthesis strategy to
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In addition, ribo-10a was observed to spontaneously crystallize
from the reaction mixture after two cycles of cyanovinylation
and ammonolysis5. As arabino-10a (refs 4,37) and ribo-10a
(refs 5,6) are both key intermediates en route to pyrimidine
ribonucleotides this additional synthetic strategy further increases
the potential of 10a as a prebiotically plausible precursor
of RNA.
Purine elaboration. We next investigated the synthesis of purine
moieties. The oligomerization of hydrogen cyanide has widely
been proposed as a key route to purine nucleobases3,7,9–11, and
guided by the recently reported synthesis of purine precursors
from aminonitrile 2b7, we recognized that, constitutionally,
2b and it’s hydrolysis product 2c (Figs 2 and 4)38–42, have the
ideal ambident reactivity to substitute thione 1 and then cyclize to
build the imidazole moiety of purine nucleobases upon a sugar
scaffold tethered by the 8,20-anhydro-linker required for
phosphorylation and C20-stereochemical inversion (Fig. 2)4,43.
Although the stability of trimer 2b is limited under high-pH
conditions, it is a key intermediate in the oligomerization of
hydrogen cyanide and is both stable and isolable at low pH.
Furthermore, 2b can be readily converted into aminonitrile 2c42,
which is stable across a broad pH range. Accordingly, we next
incubated thione 1c together with aminonitrile 2c in water
between pH 3 and 6, chosen as the pH range required for the
quantitative synthesis of anhydrocytidine 11 from
aminooxazoline 10a during pyrimidine nucleotide synthesis4.
Good yields of aminooxazoline 10c (81%) were observed upon
incubation of 1c (0.25M) and aminonitrile 2c (0.5M) at pH 4.5
for 8 h at room temperature. Furthermore, the product was
observed to undergo facile cyclization to give key intermediate
aminoimidazole 16c in up to 59% yield (over four steps from 1a
in water without requiring puriﬁcation of intermediates). It is of
particular note that 16c was observed to directly crystallize
from water in these crude reaction mixtures—albeit in lower
yield (13%) than can be recovered chromatographically. Direct
crystallization of aminoimidazole 16c from water is a plausible
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prebiotic mechanism to purify material during sequential
chemical reactions, and crystallization could allow the
accumulation of reservoirs of aminoimidazole 16c under
prebiotically plausible conditions5. The cyclization of 10c was
observed but sluggish at pH 4–5, more rapid at pH 7–9 and
highly facile at pH 11–13. It is of note that although thione 1c has
previously been reported to be unreactive to nucleophiles32,
displacement occurs readily with aminonitriles at pH 3–6, and
aminooxazolines 10b–d can all be synthesized from S-alkyl thione
1c providing access to aminoimidazoles 16b (15%) and 16c (59%)
and aminooxazoline 10d (76%). It is likely that the combination
of thione protonation (1c pKaH¼ 2.4) and the remarkably low
amine pKa (decreased through the inductive effect of the nitrile
moiety; 2b pKaH¼ 6.5 (ref. 44), 2c pKaH¼ 3.4, 2d pKaH¼ 5.6;
Supplementary Figs 8–11)45 results in the now facile
displacement of sulﬁde from S-alkyl thione 1c. Furthermore,
although aminonitrile 2b is a less efﬁcient nucleophile than
aminonitrile 2c, the dinitrile 10b cyclizes much more rapidly than
nitrile 10c, and consequently quantitatively yields 16b after 1 h at
pD 9. The improved efﬁciency of dinitrile cyclization is likely due
to both nitrile-nucleophile effective molarity and the increased
electron withdrawal of the a-nitrile with respect to the a-amide. It
is also noted that though reaction of 1c with glycine nitrile (2d)
yielded aminooxazoline 10d in excellent (76%) yield, cyclization
of 10d was not observed under any condition investigated and
was readily isolated as the uncyclized aminooxazoline (61%). The
observed differential reactivity of purine precursors 10b and 10c,
with respect to 10d, demonstrates an inherent and important
selectivity for the cyclization of purine precursors.
To assemble the purine heterocycle from key aminoimidazole
intermediates 16b–c a ﬁfth carbon is required, and hydrogen
cyanide derivatives again appeared to be the ideal prebiotic choice
to convert aminoimidazoles 16b–c to anhydropurines 17A and
17I. To test this hypothesis, we incubated 16b and 16c in
formamide at 100 C and observed direct conversion to 17A
(10%, 96 h) and 17I (3%, 72 h) (Fig. 5). Pleasingly, addition
of formamidine (10 equiv.) markedly improved the yield and
rate of anhydro-adenosine 17A synthesis (65%, 5 h; Fig. 5 and
Supplementary Fig. 29); however, formamidine only marginally
improved the yield of inosine 17I (11%, 48 h). It is therefore of
note canonical nucleobase adenine (A) is efﬁciently synthesized,
but wobble base-pairing inosine (I) is only ineffectually
synthesized46. Accordingly, our results suggest that further
investigation of the concomitant elaboration of aminoimi-
dazoles 16b and 16c may uncover conditions leading to both
anhydro-adenosine 17A and anhydro-guanosine 17G. Indeed,
incubation of 16b and 16c in formamide/formamidine at 100 C
for 5 h yields abundant anhydro-adenosine 17A (60%), but only
4% 17I alongside 35% residual 16c. However, we have not
observed the synthesis of 17G within the limits of detection upon
incubation of 16c with cyanate, urea or cyanogen in formamide
at 100 C.
Phosphorylation and stereochemical inversion. Efﬁcient phos-
phorylation of pyrimidine 11 is achieved by drying an aqueous
solution of 11, urea/formamide, and inorganic phosphate4.
Phosphorylation is selective for the 30-OH, leading into
intramolecular rearrangement of 11-30-phosphate to the
cytidine-20,30-cyclic phosphate 3C with the desired b-ribo-
stereochemistry. Both kinetic and thermodynamic properties of
this system control selection; n-p* donation suppresses
nucleophilicity of the 50-hydroxyl and monophosphate synthesis
is reversible4,47–51, whereas 20,30-cyclic phosphates are generated
by a different mechanism and are synthesized irreversibly3,4,48.
Interestingly, single crystal x-ray diffraction of purines 17A and
17I demonstrated not only that the anhydronucleoside bond had
been retained in the required site to activate the anhydropurines
for arabino-ribo stereochemical inversion but also that, in the
solid state, an observable interaction between the 50-hydroxyl and
8-carbon atom was displayed. It is particularly of note that there
is a striking similarity between the crystal structures of
anhydrocytidine 11 (refs 4,47), and anhydropurines 17A52 and
17I (Fig. 6). Therefore, we next investigated the phosphorylation
of anhydropurines 17A and 17I, ﬁnding that both were smoothly
converted to 20,30-cyclic phosphates (55–70%); conversion to
8-oxo-adenosine 3OA (22%þ 33% 20,30-cyclic-50-bisphosphate
18OA) and 8-oxo-inosine 3OI (38%þ 32% 20,30-cyclic-50-
bisphosphate 18OI) was observed under urea-mediated
phosphorylation (Fig. 6 and Supplementary Table 2). These
phosphorylations of 17A and 17I were remarkably clean; we
suggest that the smooth conversion of 17A and 17I to
ribonucleotide cyclic phosphates can, in part, be attributed to
the stability of the 8,20-anhydronucleoside linkage53. Whereas 11
is readily and rapidly hydrolysed in aqueous solution (pH46.5),
and signiﬁcant hydrolysis of 11 is observed under urea-mediated
phosphorylation, preventing intramolecular inversion and cyclic
phosphate formation, 17A and 17I are remarkably resistant to
hydrolysis. Even upon extended incubation at elevated pH 17A
and 17I do not undergo hydrolysis. Instead, 17A undergoes
isomerization to 8,50-anhydronucleoside 19 (55%, pH 11,
40 C, 24 h) and oxirane 20 (60%, pH 13, 40 C, 2 h) rather
than hydrolysis (Fig. 6 and Supplementary Fig. 34). Furthermore,
due to the irreversible nature of 20,30-cyclic phosphate synthesis,
further incubation of 3OA/18OA (22%þ 33%) with a diol, for
example glycerol (10 equiv.) or cytidine (1 equiv.), leads to an
increased yield of cyclic phosphate 3OA (38% and
41%, respectively) by sequestering phosphate from the
(reversible) equilibrium with the 50-phosphate moiety of
18OA (Supplementary Table 2), demonstrating the predis-
position of cyclic phosphate synthesis during urea-mediated
phosphorylation.
Chemical divergence of purines and pyrimidines. Given the
importance of the biochemical interplay between purines and
pyrimidines, we next sought to investigate the concomitant
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Figure 5 | Aminoimidazole formylation. Incubation of aminoimidazole
(16b–c) in formamidine/formamide solution yields anhydropurines 17A and
17I, respectively. Formamidine and hydrogen cyanide in formamide provide
comparable yields for formylation of 16c, whereas formamidine provides an
excellent yield of 17A from 16b likely exploiting the electrophilicity of the
nitrile moiety of 16b.
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synthesis of both classes of nucleotide. Interestingly, ammonia
(2a) displacement of thiolate 13 from cyanovinyl adduct 1b
(Fig. 3) results in divergent synthesis of aminooxazoline 10a and
thione 1a in comparable yields. This reaction seemed ideally
suited to establish the chemical divergence required for the
concomitant synthesis of the purine and pyrimidine ribonucleo-
tides. Owing to the increased nucleophilicity of thione 1a
with respect to aminooxazoline 10a, 1a can be quantitatively and
chemoselectively re-cyanovinylated in the presence of 10a or
with excess cyanoacetylene (8) concomitant synthesis of
anhydronucleoside 11 and anhydronucleoside precursor 1b can
be achieved with remarkable efﬁciency (Supplementary Figs 6
and 7). Furthermore, reaction of 1b with aminonitrile 2c is
achieved with good selectivity in the presence of either 10a or 11,
allowing for the concomitant synthesis of pyrimidine
anhydronucleosides 11 and purine anhydronucleoside precursor
16c through the repeated action of cyanoacetylene (8), ammonia
(2a) and aminonitrile 2c upon a single nucleotide precursor
1a (Supplementary Figs 24–26). The direct formylation of
16c in the presence of anhydronucleoside 11 is observed to
yield 17A (53%) alongside 45% residual 11 after 3 h (Supple-
mentary Figs 31 and 32). Finally, we also demonstrated the
simultaneous phosphorylation and intramolecular inversion of
both pyrimidine and purine anhydronucleosides 11 and 17A in
comparable 44% and 34% yields, respectively, by urea-mediated
phosphorylation. The remarkable parity between the reactions
that yield pyrimidine and 8-oxo-purine nucleotides, and
the observed tolerance for the simultaneous pyrimidine and
purine synthesis, suggests that the 8-oxo-purines may have
formed a bridge between prebiotic and biological information
transfer, thereby facilitating access to the prebiotic synthesis
of RNA.
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Figure 6 | Urea-mediated phosphorylation of 8,20-O-cyclo-purines. (a) Urea-mediated phosphorylation of 8,20-O-cyclo-adenine (17A) and 8,20-O-cyclo-
inosine (17I) to yield 8-oxo-adenosine-20,30-cyclic phosphate (3OA) and 8-oxo-inosine-20 ,30-cyclic phosphate (3OI). (b) Equilibration of 8,20-O-cyclo-
adenine (17A) with 8,50-anhydro-8-oxyadenine (19) and 20 ,30-anhydro-8-oxo-adenosine (20) upon incubation in alkaline solution. (c) Urea-mediated
conversion of bisphosphate 18 to monophosphate 3, driven by the irreversible synthesis of 20,30-cyclic phosphates. (d) Single crystal X-ray structures of
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Structure 11 was reported in ref. 4 and is shown for comparison to structures 17A and 17I.
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Discussion
We have demonstrated the generational relationship between
pyrimidine and purine nucleotides by constructing both hetero-
cycles on the same sugar scaffold. The formal (C8)-oxidation level
of the 8-oxo-purine moiety allows constitutional assembly of the
8-oxo-purine ribonucleotides at the same oxidation level as the
canonical pyrimidine ribonucleotides. It is also of note that
glycine nitrile adduct 10d, which is not at the correct oxidation
level to yield an aminoimidazole, is not observed to undergo
cyclization; cyclization is only observed with hydrogen
cyanide trimers 10b and 10c to form the core imidazole motif
of the purines. These highly selective cyclizations strongly
suggest that renewed investigation of prebiotic aminonitrile 2b
is warranted7,54, avoiding the uncontrolled high-pH oligo-
merization of hydrogen cyanide. The recent observation that
stepwise redox coupling of cyanide and aldehydes, under mild
photoredox conditions, negates the requirement for uncontrolled
high-pH formaldehyde oligomerization during prebiotic sugar
synthesis25, suggests that similar redox coupling strategies could
provide an alternative mechanism for hydrogen cyanide
oligomerizations in a controlled and stepwise manner. We are
also currently investigating the chemoselective reduction of the
8-oxo-purine ribonucleotide-20,30-cyclic phosphates 3OA and
3OI to the canonical ribonucleotides 3A and 3I. However, given
the strongly disfavoured Hoogsteen pairing in RNA55, it is
also possible that the 8-oxo-purine ribonucleotides would
allow for reasonably accurate information transfer during the
non-enzymatic copying of RNA templates. Given the parity
between pyrimidine and 8-oxo-purine ribonucleotide-20,30-cyclic
phosphate 3OA and 3OI syntheses, 3OA and 3OI are good
candidates for monomeric units in the early stage of replication
and template-directed RNA synthesis. Moreover, 8-oxo-purines
have remarkably stable glycosidic linkages56,57, and when
incorporated into RNA strands can mimic the function of a
ﬂavin in photorepair suggesting this motif could have provided
an essential role in prebiotic redox and repair processes17.
Although purine-pyrimidine Watson–Crick base pairing is
thermodynamically less stable with 8-oxo-nucleotides58, the
resulting lower melting temperature of the RNA duplex may
have been advantageous by facilitating thermal strand separation.
Accordingly, our results suggest that further investigation of the
informational and functional properties of the 8-oxo-purine
ribonucleotides is warranted.
Methods
2-Thiooxazole (4b). Glycolaldehyde (5; 1 g, 16.7mmol) and potassium thiocya-
nate (3.24 g, 33.3mmol) were dissolved in water (3ml). The mixture was cooled to
0 C and HCl (37%, 2.10ml) was added drop wise. The reaction mixture was
incubated for 2 h at room temperature and then at 80 C, and NMR spectra were
periodically acquired. After 24 h the starting material had been consumed and the
reaction was cooled to room temperature (Supplementary Fig. 1). The organics
were then extracted into ethyl acetate (3 50ml), washed with brine (3 30ml)
and dried over MgSO4. The solvent was removed under reduced pressure and the
resulting solids were crystallized from CH2Cl2 to yield 2-thiooxazole (4b; 1.43 g,
14.2mmol, 85%) as a yellow crystalline solid (Supplementary Fig. 61). M.p.
140–144 C (Lit 147 C (ref. 27)). IR (solid, cm 1) 3,117 (NH), 1,587 (C¼C),
1,478 (C¼ S). 1H NMR (600MHz, D2O) 7.33 (1H, d, J¼ 4.5Hz, H4), 7.05 (1H, d,
J¼ 4.5Hz, H5). 13C NMR (151MHz, D2O) 188.1 (C2), 130 (C4), 117.2 (C5).
HRMS (m/z) calculated for C3H3NOS [M]þ , 100.9930; found, 100.9930.
Crystallographic and reﬁnement parameters are shown in Supplementary Table 4.
Pentose oxazolidinone thiones (1a). 2-Thiooxazole (4b; 75.6mg, 0.75mmol) and
4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS; 20mg; internal standard) were
dissolved in D2O (1.5ml) to give a 500mM solution of 4b. The solution was
adjusted to pD 7 with NaOD (4M) and 250 or 500 ml was added to glyceraldehyde*
(7; 500mM or 1M). Solutions were made up to 500 ml with D2O where necessary.
The solutions were stirred at 60 C for 24 h and the solution was re-adjusted to pD
7 every 6 h (if necessary). Aliquots (50ml) were taken after 24 h, diluted with D2O
(450 ml) and analysed by NMR spectroscopy. The presence of 1a was conﬁrmed by
spiking with authentic samples (Supplementary Methods). Yields were calculated
by measuring the ratio of product 1a:DSS at 24 h (Supplementary Table 1 and
Supplementary Figs 2 and 3). *2-Thiooxazole (4b) reacts with rac-, D- and
L-glyceraldehyde (7) to furnish rac-, D- and L-pentose oxazolidinone thiones (1a),
respectively.
Ribofuranosyl oxazolidinone thione (ribo-1a). Overall, 67% from ribose
(Supplementary Methods) after 4 days at 60 C (Supplementary Fig. 54). M.p.
172–175 C decomp. (Lit 167–168 C59). IR (Solid, cm 1) 3,438 (NH), 3,329 (OH),
2,993, 2,920, 2,902 (CH), 1,521 (C¼ S). 1H NMR (600MHz, D2O) 5.94 (1H, d,
J¼ 5.4Hz, H10), 5.35 (1H, t, J¼ 5.4Hz, H20), 4.26 (1H, dd, J¼ 9.3, 5.4Hz, H30),
3.97 (1H, ABX, J¼ 12.6, 1.9 Hz, H50), 3.79 (1H, ddd, J¼ 9.3, 4.9, 1.9Hz, H40),
3.76 (1H, ABX, J¼ 12.6, 4.9 Hz, H500). 13C NMR (151MHz, D2O) 191.1 (C2),
88.9 (C10), 85.8 (C20), 79.2 (C40), 70.8 (C30), 59.9 (C50). HRMS (m/z) calculated for
C6H10NO4S [MþHþ ]þ , 192.0331; found, 192.0340. Crystallographic and
reﬁnement parameters are shown in Supplementary Table 3.
Arabinofuranosyl-oxazolidinone thione (arabino-1a). Overall, 65% from
arabinose (Supplementary Methods) after 6 days at 60 C (Supplementary Fig. 55).
M.p. 137–139 C (Lit 132–133 C59). IR (Solid, cm 1) 3,394 (NH), 3,299 (OH),
2,991, 2,943, 2,931, 2,871 (CH), 1,482 (C¼ S). 1H NMR (600MHz, D2O) 6.07
(1H, d, J¼ 5.8Hz, H10), 5.33 (1H, d, J¼ 5.8Hz, H20), 4.51 (1H, s, H30), 4.25
(1H, m, H40), 3.63 (1H, ABX, J¼ 12.4, 5.3 Hz, H50), 3.51 (1H, ABX, J¼ 12.4,
7.5 Hz, H500). 13C NMR (151MHz, D2O) 190 (C2), 92.5 (C20), 90.5 (C10),
87.8 (C40), 75.2 (C30), 61.6 (C50). HRMS (m/z) calculated for C6H10NO4S
[MþHþ ]þ , 192.0331; found, 192.0332. Crystallographic and reﬁnement
parameters are shown in Supplementary Table 3.
Xylofuranosyl oxazolidinone thione (xylo-1a). Overall, 46% from xylose
(Supplementary Methods) after 14 days at 60 C (Supplementary Fig. 56). M.p.
133–135 C (Lit. 129–130 C59). IR (Solid, cm 1) 3,251 (OH), 2,930 (CH), 1,488
(C¼ S). 1H NMR (600MHz, D2O) 6.07 (1H, d, J¼ 5.5Hz, H10), 5.29 (1H, d,
J¼ 5.5Hz, H20), 4.52 (1H, d, J¼ 2.8Hz, H30), 4.04 (1H, ddd, J¼ 7.4, 4.3, 2.8 Hz,
H40), 3.96 (1H, ABX, J¼ 12, 4.3Hz, H50), 3.84 (1H, ABX, J¼ 12, 7.4 Hz, H500).
13C NMR (151MHz, D2O) 190.3 (C2), 91.1 (C20), 89.5 (C10), 80.8 (C40), 73.5 (C30),
59.5 (C50). HRMS (m/z) calculated for C6H10NO4S [MþHþ ]þ , 192.0331; found,
192.0332. Crystallographic and reﬁnement parameters are shown in
Supplementary Table 4.
Lyxopyranosyl oxazolidinone thione (p-lyxo-1a). Overall, 20% from lyxose
(Supplementary Methods) after 7 days at 60 C (Supplementary Fig. 57)60. M.p.
185–187 C (Lit 178 C59). IR (Solid, cm 1) 3,342 (NH), 3,237, 3,130 (OH), 2,975
(CH), 1,496 (C¼ S). 1H NMR (600MHz, D2O) 5.74 (1H, d, J¼ 6.1Hz, H10), 5.16
(1H, dd, J¼ 6.1, 3.2 Hz, H20), 4.02 (1H, dd, J¼ 7.5, 3.2Hz, H30), 3.95–3.89 (2H, m,
H40 H50), 3.65–3.70 (1H, m, H500). 13C NMR (151MHz, D2O) 191.4 (C2), 84 (C20),
83.8 (C10), 70.3 (C30), 68.9 (C40), 66.2 (C50). HMBC was observed between H10 and
C50 indicating pyranosyl structure. HRMS (m/z) calculated for C6H10NO4S
[MþHþ ]þ , 192.0331; found, 192.0328. Crystallographic and reﬁnement
parameters are shown in Supplementary Table 3.
Lyxofuranosyl oxazolidinone thione (f-lyxo-1a). 1H NMR (600MHz, D2O) 5.87
(1H, d, J¼ 5.8Hz, H10), 5.40 (1H, t, J¼ 5.8Hz, H20), 4.70 (1H, dd, J¼ 6.4, 5.8Hz,
H30), 4.31 (1H, ddd, J¼ 9, 6.4, 3.9 Hz, H40), 3.81 (1H, ABX, J¼ 12.4, 3.9Hz, H50),
3.56 (1H, ABX, J¼ 12.4, 9Hz, H500). Crystallographic and reﬁnement parameters
are shown in Supplementary Table 3.
(S-Z-cyanovinyl)-arabinofuranosyl-oxazolidinone thione (arabino-1b).
Arabinofuranosyl-oxazolidinone thione (arabino-1a; 2.50 g, 13.1mmol) was added
to an aqueous solution of cyanoacetylene (8; 20ml, 1M). After stirring the reaction
mixture for 1 h at room temperature, it was lyophilized to yield (S-Z-cyanovinyl)-
arabinofuranosyl-oxazolidinone thione (arabino-1b; 3.26 g, quant.) as a white solid,
which was used without further puriﬁcation (Supplementary Fig. 59). An analytical
sample was crystallized from ethanol/water (1:4). M.p. 197–203 C. IR (solid,
cm 1) 3,372 (OH), 3,068, 3,056, 2,956 (CH), 2,212 (CN), 1,601 (C¼N), 1,575
(C¼C). 1H NMR (600MHz, D2O) 7.83 (1H, d, J¼ 10.5Hz, H4), 6.18 (1H, d,
J¼ 6Hz, H10), 5.97 (1H, d, J¼ 10.5Hz, H5), 5.20 (1H, d, J¼ 6Hz, H20), 4.43
(1H, m, H30), 4.13 (1H, m, H40), 3.62 (1H, ABX, J¼ 12.4, 4.6Hz, H50), 3.53
(1H, ABX, J¼ 12.4, 6.3Hz, H500). 13C NMR (151MHz, D2O) 167.3 (C2),
143.5 (C5), 115.9 (C6), 100.3 (C4, C10), 91.5 (C20), 86.4 (C40), 76 (C30), 61.5 (C50).
HRMS (m/z) calculated for C9H10N2O4S [MHþ ] , 243.0440; found, 243.0447.
Crystallographic and reﬁnement parameters are shown in Supplementary Table 4.
(S-Z-cyanovinyl)-ribofuranosyl oxazolidinone thione (ribo-1b). Ribofuranosyl
oxazolidinone thione (ribo-1a; 331mg, 1.73mmol) was added to an aqueous
solution of cyanoacetylene (8; 5ml, 1M). After stirring the reaction mixture for 1 h
at room temperature, it was lyophilized to yield (S-Z-cyanovinyl)-ribofuranosyl
oxazolidinone thione (ribo-1b; 400mg, 1.65mmol, 95%) as a white solid, which
was used without further puriﬁcation (Supplementary Fig. 58). M.p. 193–198 C.
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IR (solid, cm 1) 3,344 (OH), 3,055, 2,926, 2,876 (CH), 2,218 (CN), 1,653
(C¼N), 1,601 (C¼C). 1H NMR (600MHz, D2O) d 7.88 (1H, d, J¼ 10.8Hz, H4),
6.10 (1H, d, J¼ 5.4Hz, H10), 5.99 (1H, d, J¼ 10.8Hz, H5), 5.22 (1H, t, J¼ 5.4Hz,
H20), 4.27 (1H, dd, J¼ 9.3, 5.4Hz, H30), 3.95 (1H, ABX, J¼ 13, 2.3Hz, H50), 3.76
(1H, ABX, J¼ 13, 4.7 Hz, H500), 3.60 (1H, ddd, J¼ 9.3, 4.7, 2.3Hz, H40). 13C NMR
(151MHz, D2O) d 168.4 (C2), 143.7 (C5), 116 (C6), 100.3 (C4), 98.9 (C10), 84.7
(C20), 78.9 (C40), 70.9 (C30), 59.9 (C50). [MHþ ] C9H10N2O4S calcd 243.0493,
found 243.0541.
Arabinofuranosyl-(2-thiomethyl)-oxazolidinone (arabino-1c). (S-Z-cyanovi-
nyl)-arabinofuranosyl-oxazolidinone thione (arabino-1b; 24.2mg, 0.1mmol) and
DSS (NMR standard, 15mg) were dissolved in D2O (500 ml). Sodium acetate buffer
(500 ml, 2M, pD 6, D2O) was added and the solution adjusted to pD 6 with 1M
NaOD/DCl. Methanethiol (generated by dropping sodium thiomethoxide solution
(21% v/v) onto anhydrous monobasic sodium phosphate at room temperature) was
bubbled through the solution for 10min. Further methanethiol gas was added
every 2 h. After 6 h the solution was sparged with nitrogen, then cyanoacetylene
(8; 200ml, 1M) was added and the mixture was left to stand for 2 h. The solution
was again saturated with methanethiol gas for 10min and incubated for 16 h
before NMR spectra were acquired (Supplementary Figs 13, 14 and 60). NMR
analysis indicated the presence of arabinofuranosyl-(2-thiomethyl)-oxazolidinone
(arabino-1c, 50%, Supplementary Methods), arabinofuranosyl-oxazolidinone
thione (arabino-1a, 15%) and arabinofuranosyl-oxazolidinone (arabino-22, 12%,
Supplementary Methods).
N3-arabinofuranosyl-2,20-anhydroquinazolinedione (arabino-12a).
(S-Z-cyanovinyl)-arabinofuranosyl-oxazolidinone thione (arabino-1b; 100mg,
0.40mmol) was added to a solution of anthranilic acid (14; 170mg, 1.20mmol) in
water (10ml) at pH 6. The reaction was stirred for 18 h at room temperature
(Supplementary Fig. 15), after this time the crude was lyophilized and puriﬁed by
FCC eluting with (EtOAc:MeOH 9:1) to yield N3-arabinofuranosyl-2,20-anhy-
droquinazolinedione (arabino-12a; 40mg, 0.14mmol, 36%) as a white solid
(Supplementary Fig. 64). M.p. 234–238 C. IR (solid, cm 1) 3,422 (OH), 3,067,
2,959, 2,929, 2,875 (CH), 1,699 (C¼O), 1,644 (C¼N), 1,608 (C–N), 1,562
(C¼C). 1H NMR (600MHz, D2O) d 8.15 (1H, d, J¼ 8.3Hz, H–Ar), 7.84
(1H, t, J¼ 7.7Hz, H–Ar), 7.48 (2H, m, H–Ar), 6.74 (1H, d, J¼ 5.8Hz, H10),
5.43 (1H, d, J¼ 5.8Hz, H20), 4.69 (1H, s, H30), 4.40 (1H, br s, H40), 3.59 (1H, ABX,
J¼ 13, 3.5Hz, H50), 3.57 (1H, ABX, J¼ 13, 4.3Hz, H500). 13C NMR (151MHz,
D2O) d 162.7 (C4), 156 (C2), 148.6 (C6), 136.9 (C8), 127.3 (C10), 126.3 (C9),
125.7 (C7), 118.3 (C5), 89.9 (C40), 89 (C20), 88.4 (C10), 75.8 (C30), 61.5 (C50).
HRMS (m/z): [Mþ ] C13H12N2O5 calcd 276.07462, found 276.07395. Crystal-
lographic and reﬁnement parameters are shown in Supplementary Table 4.
N3-ribofuranosyl-2,20-anhydroquinazolinedione (ribo-12a). (S-Z-cyanovinyl)-
ribofuranosyl oxazolidinone thione (ribo-1b; 30.3mg, 0.125mmol) was added to
a solution of anthranilic acid (14; 34.3mg, 0.25mmol) in water (0.5ml) at pH 6.
The reaction was stirred for 18 h at room temperature (Supplementary Fig. 16),
then left to stand at 5 C overnight. The obtained crystals were ﬁltered, washed with
water (0.5ml), ether (5ml) and dried under vacuum to give N3-ribofuranosyl-2,20-
anhydroquinazolinedione (ribo-12a; 10mg, 0.036mmol, 29%) as a white solid. An
analytical sample was recrystallized from hot water (Supplementary Fig. 63).
M.p. 230–235 C, decomp. IR (solid, cm 1) 3,431 (OH), 3,170 (OH), 2,927 (CH),
1,697 (C¼O), 1,645 (C¼N), 1,608 (C–N), 1,565 (C¼C). 1H NMR (600MHz,
D2O) d 8.22 (1H, d, J¼ 8.1Hz, H–Ar), 7.91 (1H, t, J¼ 8.1Hz, H–Ar), 7.58 (1H, d,
J¼ 8.1Hz, H–Ar), 7.55 (1H, t, J¼ 8.1Hz, H–Ar), 6.71 (1H, d, J¼ 5.4Hz, H10),
5.52 (1H, t, J¼ 5.4Hz, H20), 4.49 (1H, dd, J¼ 9.4, 5.4Hz, H30), 4.02 (1H, ABX,
J¼ 13, 2.3Hz, H50), 3.98 (1H, ddd, J¼ 9.4, 4.1, 2.3Hz, H40), 3.85 (1H, ABX, J¼ 13,
4.1Hz, H500). 13C NMR (151MHz, D2O) d 162.9 (C4), 156.5 (C2), 148.8 (C6),
137 (C8), 127.4 (C10), 126.4 (C9), 126 (C7), 118.6 (C5), 87 (C10), 82 (C20),
80.6 (C40), 70.2 (C30), 59.7 (C50). HRMS (m/z): [MþHþ ]þ C13H12N2O5 calcd
277.0825, found 277.0820. Crystallographic and reﬁnement parameters are shown
in Supplementary Table 5.
Arabinofuranosyl-N-acetonitrile-aminooxazoline (arabino-10d). Glycine
nitrile.HCl (2d.HCl; 2.7 g, 29.2mmol) was dissolved in water (10ml) and the
solution was adjusted to pH 4.5 with NaOH (4M) (Supplementary Fig. 8).
Arabinofuranosyl-(2-thiomethyl)-oxazolidinone (arabino-1c; 2 g, 9.78mmol) was
added in a single portion and the solution was re-adjusted to pH 4.5. The reaction
was stirred for 2 h at room temperature whilst N2 constantly agitated the solution
(Supplementary Figs 20 and 21). The solution was neutralized with sodium
hydroxide (4M), and silica gel (5 g) was added. The suspension was concentrated
to a free ﬂowing powder that was puriﬁed by ﬂash column chromatography (FCC),
eluting with MeOH/CHCl3 (1:9–2:8). The fractions containing the product were
concentrated to yield arabinofuranosyl-N-acetonitrile-aminooxazoline (arabino-
10d; 1.27 g, 5.96mmol, 61%) as a yellow oil (Supplementary Fig. 62). IR (neat,
cm 1) 3,246 (OH), 2,926 (CH), 2,251 (CN), 1,648 (C¼N). 1H NMR (600MHz,
D2O) 6 (1H, d, J¼ 5.5Hz, H10), 5.04 (1H, d, J¼ 5.5Hz, H20), 4.38 (1H, d,
J¼ 2.8Hz, H30), 4.21 (2H, s, C4), 4.07 (1H, ddd, J¼ 6.6, 5.5, 2.8Hz, H40), 3.60 (1H,
ABX, J¼ 12.2, 5.5Hz, H50),
3.55 (1H, ABX, J¼ 12.2, 6.6, H500). 13C NMR (151MHz, D2O) 163.3 (C2),
118.3 (C5), 97.6 (C10), 89.8 (C20), 85.9 (C40), 75.8 (C30), 61.9 (C50), 31.8 (C4).
HRMS (m/z) calculated for C8H12N3O4 [MþHþ ]þ , 214.0828; found, 214.0813.
2,20-Anhydro-5-aminoimidazole-4-carboxamide-b-furanosylarabinoside (16c).
To a solution of 2-aminocyanoacetamide (2c; 108mg, 1.09mmol) in water (1ml) at
pH 4.5 was added arabinofuranosyl-(2-thiomethyl)-oxazolidinone (arabino-1c;
300mg, 1.46mmol). The resultant mixture was stirred for 3 h at 45 C and the pH of
the reaction was kept between 4.3 and 4.7 during the course of the reaction. After 3 h
the pH of the reaction was raised to pH 8 and then left to stir overnight at 45 C
(Supplementary Figs 22–26). After 24 h white solids precipitated from the crude
mixture, which were ﬁltered, washed and dried to yield 2,20-anhydro-5-aminoimi-
dazole-4-carboxamide-b-furanosylarabinoside (16c; 37.2mg, 0.15mmol, 13%) as
white solid (Supplementary Fig. 67). M.p. 234–238 C. IR (solid, cm 1) 3,493 (H2N–
C¼O), 3,359 (H2N–C), 3,210 (OH), 1,638 (C¼O), 1,581 (C¼N), 1,533 (C¼C). 1H
NMR (600MHz, D2O) 6.46 (1H, d, J¼ 5.4Hz, H10), 5.68 (1H, d, J¼ 5.4Hz, H20)),
4.60 (1H, br s, H30), 4.38 (1H, ddd, J¼ 6.8, 4.9, 1.9Hz, H40), 3.56 (1H, ABX, J¼ 12.4,
4.9Hz, H50), 3.42 (1H, ABX, J¼ 12.4, 6.8Hz, H500). 13C NMR (151MHz, D2O) 169.1
(C6), 152.6 (C2), 140 (C5), 109.9 (C4), 97.9 (C20), 89.3 (C40), 86.5 (C10), 75.3 (C30),
61.5 (C50). HRMS (m/z) calculated for C9H12N4O5 [MþHþ ]þ , 257.0880; found,
257.0882. Crystallographic and reﬁnement parameters are shown in Supplementary
Tables 5 (D-isomer) and 6 (L-isomer).
2,20-Anhydro-5-aminoimidazole-4-carbonitrile-b-furanosylarabinoside (16b).
Aminomalonitrile p-toluenesulfonate (126.7mg, 0.5mmol) was dissolved in D2O
(450 ml) and the pD was adjusted to 3 with NaOD (4M). A solution of DSS
(D2O, 50 ml, 244mM) was added followed by arabinofuranosyl-(2-thiomethyl)-
oxazolidinone (arabino-1c; 25.6mg, 0.125mmol). The pD was re-adjusted to 3 and
the mixture was stirred at room temperature for 3 h. An aliquot (50 ml) was added
to ammonium hydroxide in D2O (450 ml, 100mM, pD 9) and the solution was
adjusted to pD 9 with NaOD (4M) and incubated for 1 h at room temperature
(Supplementary Figs 27 and 28). Spiking with authentic samples and calibration to
an internal standard conﬁrmed yield of 15% 2,20-anhydro-5-aminoimidazole-4-
carbonitrile-b-furanosylarabinoside (16b; Supplementary Methods). M.p.
210–220 C decomp. IR (Solid, cm 1) 3,423 (H2N–C), 3,316 (OH), 2,194 (CN),
1,649 (C¼N), 1,568 (C¼C). 1H NMR (600MHz, DMSO) 6.55 (1H, br s, NH2),
6.19 (1H, d, J¼ 5.2Hz, H10), 5.82 (1H, br s, 30OH), 5.46 (1H, d, J¼ 5.2Hz, H20),
4.98 (1H, t, J¼ 5.5Hz, 50OH), 4.31 (1H, br s, H30), 3.98 (1H, ddd, J¼ 7.3, 5.5,
2.2 Hz, H40), 3.22 (1H, ABXY, J¼ 11.2, 5.5, 5.5Hz, H50), 3.11 (1H, ABXY, J¼ 11.2,
7.3, 5.3Hz, H50). 13C NMR (151MHz, DMSO) 150 (C2), 143.8 (C4), 117.8 (C6),
97.4 (C20), 88.4 (C40), 86.6 (C4), 85.3 (C10), 74 (C30), 60.6 (C50). HRMS (m/z)
calculated for C9H10N4O4 [MþHþ ]þ , 239.07748; found, 239.07750. Crystal-
lographic and reﬁnement parameters are shown in Supplementary Table 5 and
Supplementary Fig. 66).
8,20-O-anhydro-9-b-arabinofuranosyl-cycloadenosine (17A). Method A.
2,20-Anhydro-5-aminoimidazole-4-carbonitrile-b-furanosylarabinoside
(16b; 4.8mg, 0.02mmol) and DSS (internal standard, 5mg) were dissolved
in D2-formamide (500 ml). The mixture was heated at 100 C and NMR spectra
were periodically acquired. The starting material had been consumed after 96 h.
The reaction mixture was cooled to room temperature, lyophilized and the residue
dissolved in methanolic ammonia (to remove 30 and 50 formyl groups observed
during reaction in neat formamide) for 30min. The reaction was concentrated to
dryness, D2O (5ml) was added and the mixture was lyophilized. The residue was
the dissolved in d6-DMSO and NMR spectra were acquired. Spiking with an
authentic sample of 8,20-O-anhydro-9-b-arabinofuranosyl-cycloadenosine
(17A, Supplementary Methods) and calibration to the internal standard (DSS)
conﬁrmed a 10% yield of 17A.
Method B. 2,20-Anhydro-5-aminoimidazole-4-carbonitrile-b-
furanosylarabinoside (16b; 4.8mg, 0.02mmol), formamidine hydrochloride
(16.1mg, 0.2mmol) and DSS (internal standard, 5mg) were dissolved in
D2-formamide (500 ml). The mixture was heated at 100 C and NMR spectra
periodically were acquired. The starting material had been consumed after 5 h. The
reaction mixture was cooled to room temperature and lyophilized. Formamidine
was observed to suppress 30 and 50 formylation and no methanolic ammonia
treatment was required. The lyophilite was dissolved in D2O (5ml) and again
lyophilized. The residue was the dissolved in d6-DMSO and NMR spectra
were acquired (Supplementary Figs 29–32). Spiking with an authentic sample of
8,20-O-anhydro-9-b-arabinofuranosyl-cycloadenosine (17A, Supplementary
Methods) and calibration to the internal standard (DSS) conﬁrmed a 65% yield of
17A (Supplementary Fig. 68). M.p. 205 C decomp. (Lit.61 210 C) IR (Solid,
cm 1) 3,297 (NH2), 3,142 (OH), 2,962, 2,883 (CH), 1,667 (C¼C), 1,623 (C¼N).
1H NMR (600MHz, D2O) 8.16 (1H, s, H2), 6.71 (1H, d, J¼ 5.5Hz, H10),
5.90 (1H, d, J¼ 5.5Hz, H20), 4.72 (1H, s, H30), 4.40 (1H, ddd, J¼ 5.5, 5.4, 4.3Hz,
H40), 3.55 (1H, ABX, J¼ 12.7, 4.3Hz, H50), 3.48 (1H, ABX, J¼ 12.7, 5.4Hz, H50).
13C NMR (151MHz, D2O) d 161.2 (C8), 154.4 (C5), 151.6 (C2), 146.2 (C4),
121.1 (C6), 99.5 (C20), 89.6 (C40), 86.5 (C10), 75.6 (C30), 61.4 (C50). HRMS (m/z):
[MHþ ] C10H11N5O4 calcd 265.08110, found 266.0866. Crystallographic and
reﬁnement parameters are shown in Supplementary Table 6.
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8,20-O-anhydro-9-b-arabinofuranosyl-cycloinosine (17I). 2,20-Anhydro-5-ami-
noimidazole-4-carboxamide-b-furanosylarabinoside (16c; 5mg, 0.02mmol) and
DSS (NMR standard, 5mg) were dissolved in D2-formamide (500 ml). The mixture
was heated at 100 C and NMR spectra were periodically acquired. The starting
material had been consumed after 72 h. The reaction mixture was cooled to room
temperature, lyophilized and the residue was treated with methanolic ammonia
(to remove 30 and 50 formyl groups) for 30min. The reaction was concentrated to
dryness, D2O (5ml) was added and the mixture was lyophilized. The residue was
dissolved in D6-DMSO and NMR spectra were acquired (Supplementary Fig. 33).
Spiking with an authentic sample of 8,20-O-anhydro-9-b-arabinofuranosyl-cycloi-
nosine (17I, Supplementary Methods) and calibration to the internal standard
(DSS) conﬁrmed a 3% yield of 17I (Supplementary Fig. 69). The addition of
formamidine hydrochloride (16.1mg, 0.2mmol) at the start of the reaction
increases the yield of 17I to 11%. M.p. 255 C (decomp). IR (Solid, cm 1) 3,216
(OH) or (NH), 3,076, 2,006, 2,953 (CH), 1,673 (C¼O), 1,598 (C¼C), 1,572
(C¼N). 1H NMR (600MHz, D2O) d 8.17 (1H, s, H2), 6.75 (1H, d, J¼ 5.5Hz,
H10), 5.91 (1H, d, J¼ 5.5Hz, H20), 4.72 (1H, s, H30), 4.42 (1H, dd, J¼ 5.4, 4.1Hz,
H40), 3.56 (1H, ABX, J¼ 12.7, 4.1 Hz, H50), 3.49 (1H, ABX, J¼ 12.7, 5.4Hz, H50).
13C NMR (151MHz, D2O) d 160.7 (C8), 158.4 (C6), 145.8 (C2), 145.6 (C5),
126 (C4), 99.5 (C20), 89.9 (C40), 86.9 (C10), 75.6 (C30), 61.4 (C50). HRMS (m/z):
[M-Hþ ]- C10H10N5O4 calcd 267.0729, found 267.0723. Crystallographic and
reﬁnement parameters are shown in Supplementary Table 6.
Phosphorylation of anhydronucleosides. Method I. Nucleoside (0.06mmol),
ammonium dihydrogen phosphate (0.06mmol) and urea (1.6mmol) were
thoroughly mixed and heat at 140 C for 20min (Supplementary Table 2). The
reaction mixture was then cooled to room temperature, dissolved in D2O (3ml)
and lyophilized. The residue was thrice dissolved in D2O (3ml) and lyophilized.
The ﬁnal lyophilite was dissolved in D2O (0.5ml) and NMR spectra were acquired
(Supplementary Figs 35 and 45). Yields were calculated based on comparison with
an internal standard (DSS) and nucleotide phosphates were puriﬁed using HPLC
(Supplementary Methods).
Method II. Nucleoside (0.06mmol), ammonium dihydrogen phosphate
(0.06mmol) and urea (0.6mmol) were suspended in formamide (0.6ml). The
reaction mixture was heated at 100 C for 72 h. The reaction was diluted D2O
(3ml) and lyophilized for 3 days (to remove formamide), diluted with D2O (3ml)
and further lyophilized. The lyophilite was dissolved in D2O (0.5ml) and NMR
spectra were acquired (Supplementary Figs 42 and 52). Yields were calculated
based on comparison with an internal standard (DSS).
Method III. Nucleoside (0.06mmol), ammonium dihydrogen phosphate
(0.06mmol) and urea (1.6mmol) were thoroughly mixed and heat at 140 C for
20min. Glycerol (44 ml, 0.6mmol) was added and the mixture was heated at 140 C
for a further 20min. The reaction mixture was then cooled to room temperature,
dissolved in D2O (3ml) and lyophilized. The residue was thrice dissolved in D2O
(3ml) and lyophilized. The ﬁnal lyophilite was dissolved in D2O (0.5ml) and NMR
spectra were acquired (Supplementary Fig. 43). Yields were calculated based on
comparison with an internal standard (DSS).
Method IV. Nucleoside (0.06mmol), ammonium dihydrogen phosphate
(0.06mmol) and urea (1.6mmol) were thoroughly mixed and heat at 140 C for
20min. Cytidine (14.6mg, 0.06mmol) was added and the mixture was heated at
140 C for a further 20min. The reaction mixture was then cooled to room
temperature, dissolved in D2O (3ml) and lyophilized. The residue was thrice
dissolved in D2O (3ml) and lyophilized. The ﬁnal lyophilite was dissolved in D2O
(0.5ml) and NMR spectra were acquired (Supplementary Fig. 43). Yields were
calculated based on comparison with an internal standard (DSS).
Method V. Nucleoside (0.03mmol), ancitabine (11; 0.03mmol), ammonium
dihydrogen phosphate (0.06mmol) and urea (0.6mmol) were suspended in
formamide (0.6ml). The reaction mixture was heated at 100 C for 72 h. The
reaction was diluted D2O (3ml) and lyophilized for 3 days (to remove formamide),
diluted with D2O (3ml) and further lyophilized. The lyophilite was dissolved in
D2O (0.5ml) and NMR spectra were acquired (Supplementary Fig. 44). Yields were
calculated based on comparison with an internal standard (DSS).
8-Oxo-adenosine-20,30-cyclic phosphate (3OA). M.p. 220 C (decomp.).
IR (Solid, cm 1) 1,711 (N–C¼N), 1,649 (N–C¼O), 1,060 (P¼O). 1H NMR
(600MHz, D2O) 8.10 (1H, s, H2), 6.11 (1H, d, J¼ 3.4Hz, H10), 5.61 (1H, ddd,
J¼ 7.8, 7, 3.4Hz, H20), 5.14 (1H, ddd, J¼ 10.9, 7, 4.9Hz, H30), 4.40 (1H, m, H40),
3.93 (1H, ABX, J¼ 12.3, 3.6Hz, H50), 3.85 (1H, ABX, J¼ 12.3, 5.5Hz, H500).
31P NMR (162MHz, D2O) 20.37 (dd, J¼ 10.9, 7.8Hz, 20 ,30cP). 13C NMR
(151MHz, D2O) 153.3 (C8), 151.8 (C2), 148.3 (C6), 146.7 (C4), 105.2 (C5),
87 (d, J¼ 5.5Hz, C10), 85.6 (d, J¼ 2.2Hz, C40), 79.8 (d, J¼ 2.2Hz, C20), 78.3 (C30),
62 (C50). HRMS (m/z): [MHþ ] for C10H12N5O7P calcd 344.0396, found
344.0390. (Supplementary Figs 36–38).
8-Oxo-adenosine-20,30-cyclic-50 bisphosphate (18OA). M.p. 235 C (decomp.).
IR (Solid, cm 1) 1,707 (N–C¼N), 1,655 (N–C¼O), 1,038 (P¼O).
1H NMR (600MHz, D2O) 8.12 (1H, s, H2), 6.11 (1H, d, J¼ 2.9Hz, H10),
5.69 (1H, td, J¼ 6.3, 2.9Hz, H20), 5.19 (1H, ddd, J¼ 12, 6.3, 5.8Hz, H30),
4.44 (1H, m, H40), 4.14 (1H, ABXY, J¼ 11.4, 5, 5Hz, H50), 4.06 (1H, ABXY,
J¼ 11.4, 6.2, 6.2Hz, H500). 31P NMR (162MHz, D2O) 20.58 (dd, J¼ 12, 6.3Hz,
20,30cP), 0.85 (br s, 50P). 13C NMR (151MHz, D2O) 153.2 (C8), 151.9 (C2),
148.2 (C6), 146.8 (C4), 105.1 (C5), 86.7 (d, J¼ 6.6Hz, C10), 84.4 (d, J¼ 7.2Hz,
C40), 79.4 (d, J¼ 2.8Hz, C20), 77.9 (C30), 64.5 (d, J¼ 3.9Hz, C50). HRMS (m/z):
[MHþ ] for C10H13N5O10P2 calcd 424.0060, found 424.0056. (Supplementary
Figs 39–41).
8-Oxo-inosine-20,30-cyclic phosphate (3OI). M.p. 310 C (decomp.). IR
(Solid, cm 1) 1,724 (C¼O), 1,674 (N–C¼O), 1,447 (C¼C), 1,063 (P¼O).
1H NMR (600MHz, D2O) 8.14 (1H, s, H2), 6.16 (1H, d, J¼ 2.9Hz, H10),
5.62 (1H, td, J¼ 6.6, 2.9Hz, H20), 5.17 (1H, ddd, J¼ 5.4, 6.6, 12.1Hz, H30),
4.38 (1H, m, H40), 3.92 (1H, ABX, J¼ 12.4, 3.9 Hz, H50), 3.85 (1H, ABX, J¼ 12.4,
5.9 Hz, H500). 31P NMR (162MHz, D2O) 20.44 (dd, J¼ 12.1, 6.6Hz, 20,30cP).
13C NMR (151MHz, D2O) 153.3 (C6), 153.2 (C8), 145.9 (C2), 145.7 (C4),
109.8 (C5), 87 (d, J¼ 6.6Hz, C10), 85.7 (d, J¼ 1.7Hz, C40), 80.2 (d, J¼ 2.2Hz, C20),
78.2 (C30), 61.8 (C50). HRMS (m/z): [MHþ ] for C10H11N4O8P calcd
345.0236, found 345.0235. (Supplementary Figs 46–48).
8-Oxo-inosine-20,30-cyclic-50 bisphosphate (18OI). M.p. 275 C (decomp.). IR
(Solid, cm 1) 1,680 (N–C¼O), 1,452 (C¼C), 1,059 (P¼O). 1H NMR (600MHz,
D2O) 8.15 (1H, s, H2), 6.16 (1H, d, J¼ 2.8Hz, H10), 5.67 (1H, td, J¼ 6.4, 2.8Hz,
H20), 5.22 (1H, ddd, J¼ 12.6, 6.4, 5.7Hz, H30), 4.45 (1H, m, H40), 4.10 (1H, ABXY,
J¼ 11.3, 4.9, 4.9Hz, H50), 4.03 (1H, ABXY, J¼ 11.3, 6.1, 6.1Hz, H500). 31P NMR
(162MHz, D2O) 20.59 (dd, J¼ 12.6, 6.4Hz, 20 ,30cP), 2.77 (br s, 50P). 13C NMR
(151MHz, D2O) 153.5 (C6), 153.2 (C8), 146.1 (C2), 145.8 (C4), 109.8 (C5),
86.8 (d, J¼ 6.6Hz, C10), 84.7 (d, J¼ 8.3Hz, C40), 79.9 (d, J¼ 2.8Hz, C20),
78.2 (C30), 64.4 (d, J¼ 4.4Hz, C50). HRMS (m/z): [M-Hþ ]- for C10H12N4O11P2
calcd 424.9900, found 424.9904. (Supplementary Figs 49–51).
Crystallography. Single X-ray diffraction data for 4b, arabino-1a, lyxo-furano-1a,
lyxo-pyrano-1a, ribo-1a, arabino-1b, arabino-12a, ribo-12a, xylo-1a and 15 were
collected using a Bruker APEX II DUO CCD diffractometer (CuKa radiation,
l¼ 1.54178Å or MoKa, l¼ 0.71073Å). The data were processed using the
Bruker SAINT V7.46A software62. All data collections were performed at low
temperatures. Diffraction data for 16b, L-16c, D-16c, 17A, 17I, 19 and 20 were
collected using an Agilent SuperNova (Dual Source) single crystal X-ray
diffractometer (CuKa radiation, l¼ 1.54184Å). The data were processed using the
CrysAlisPro programme63. All diffraction data was collected at low temperatures.
The crystal structures were solved by the direct methods procedure (using either
SHELXS-97 or SHELXS-2014/7)64 and reﬁned by least-squares methods against
F2 (using SHELXS-97 or SHELXL-2014/7)64. All non-hydrogen atoms were reﬁned
anisotropically. Hydrogen atoms afﬁliated with oxygen and nitrogen atoms were
reﬁned isotropically in positions identiﬁed in the difference Fourier map or in
geometrically constrained positions, while hydrogen atoms associated with carbon
atoms were reﬁned isotropically in geometrically constrained positions. Where
possible the absolute conﬁguration of each structure was determined through
anomalous dispersion effects observed in diffraction measurements of chiral
compound (Supplementary Crystallographic Files), for any results that were not
conclusive, owing to the lack of heavy atoms in the molecule, the absolute
conﬁguration was established by reference to an unchanged chiral center in the
synthetic sequence. The molecular structures of 4b, lyxo-furano-1a, lyxo-pyrano-
1a, ribo-1a, xylo-1a and L-arabino-16c are shown in Supplementary Fig. 53, while
the molecular structures of arabino-12a, ribo-12a are shown in Fig. 3, the
molecular structures of 15, arabino-1a, arabino-1b, arabino-16b, D-arabino-16c are
shown in Fig. 4, and the molecular structures of 17A, 17I, 19 and 20 are shown in
Fig. 6. Essential crystallographic and reﬁnement parameters relating to the reported
crystal structures are summarized in Supplementary Tables 3–7.
Data availability. The authors declare that data supporting the ﬁndings of this
study are available within the paper and its Supplementary Information ﬁles.
All relevant data is available from the authors upon reasonable request. X-ray
crystallographic data was also deposited at the Cambridge Crystallographic Data
Centre (CCDC) under the following CCDC deposition numbers: D-arabino-1a
(1522010), D-lyxo-furano-1a (1522011), D-lyxo-pyrano-1a (1522012), D-ribo-1a
(1522013), D-xylo-1a (1522014), D-arabino-1b (1522015), 4b (1522016), D-arabino-
12a (1522017), D-ribo-12a (1522018), 15 (1522019), D-16b (1522020), D-16c
(1522026), L-16c (1522024), D-17A (1522025), D-17I (1522023), D-19 (1522021)
and D-20 (1522022). These can be obtained free of charge from CCDC via
www.ccdc.cam.ac.uk/data_request/cif.
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